Company Information
USD
1.41
- (-3.4%)
NASDAQ:PLRX, PLIANT THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Address
260 Littlefield Avenue
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Hoyoung Huh,M.D.,PhD
Director
Mr. David E.I. Pyott, M.B.A.,M.D.
Director
Mr. Thomas A. McCourt
Director
Ms. Gayle A. Crowell
Director
Dr. Suzanne L. Bruhn, PhD
Director
Dr. John T. Curnutte, M.D.,PhD
Director
Mr. Darren S. Cline, M.B.A.
Director
Ms. Smital Shah, M.B.A.
Director
Dr. Katharine Knobil, M.D.
Director
Dr. Bernard Coulie, M.B.A.,M.D.,PhD
CEO/Director/President
Dr. Keith Cummings, M.B.A.,M.D.
CFO/Chief Accounting Officer
Dr. Eric Lefebvre, M.D.
Chief Medical Officer
Mr. Hans Hull, J.D.
Other Executive Officer
Mr. Mike Ouimette, J.D.
General Counsel/Secretary
Ms. Lily Cheung
Other Corporate Officer
Ownership
Institution Holdings
Deep Track Capital, LP
5,750,000 (9.545%)
BlackRock Inc
4,801,517 (7.971%)
FMR LLC
4,393,231 (7.293%)
FMR Inc
3,963,418 (6.579%)
T. Rowe Price Associates, Inc.
3,785,916 (6.285%)
First Light Asset Management, LLC
3,591,776 (5.963%)
LAURION CAPITAL MANAGEMENT LP
3,186,511 (5.290%)
Vanguard Group Inc
3,065,869 (5.089%)
CHI Advisors LLC
3,014,199 (5.004%)
Blue Owl Capital Holdings LP
3,004,199 (4.987%)
Funds Holdings
T. Rowe Price New Horizons Fund
1,907,632 (3.167%)
US Small-Cap Growth II Equity Comp
1,907,632 (3.167%)
Fidelity Growth Company Commingled Pool
1,729,098 (2.870%)
iShares Russell 2000 ETF
1,404,149 (2.331%)
Fidelity Growth Company Fund
1,360,021 (2.258%)
Vanguard Institutional Extnd Mkt Idx Tr
800,409 (1.329%)
Fidelity Small Cap Index Fund
568,299 (0.943%)
T. Rowe Price Health Sciences Fund
536,985 (0.891%)
iShares Russell 2000 Growth ETF
504,365 (0.837%)
Allspring (Lux) WW Global L/S Eq Fd
500,249 (0.830%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
